Extracorporeal Photopheresis (ECP)
Online, functionally closed photopheresis system
Single and double needle access options
Low extracorporeal volume (163mL)
Low minimum hematocrit (15%)
Process up to 8 liters of whole blood
Available in Select Countries Only.
Versatility for Therapeutic Apheresis
and Cell Collections
The Phelix device continuously montiors the intensity of UVA light, temperature of collected MNCs, and agitation to ensure delivery of the target UVA light dose.
Bi-directional communication between the Amicus and Phelix allow control of the system from these devices. Photoactivation progress and results can be monitored and viewed from the Amicus touch screen interface. Amicus reinfuses the treated cells back to the patient.
Focused on Patient Safety
- One kit for single needle or double needle access
- Qualified with ACD-A
- Automated Custom Prime for patients having a lower total blood volume and/or hematocrit
- Needle-free 8-MOP injection site contains a 0.2-micron antimicrobial filter combined with a one-way valve, creates a functionally closed pathway in the disposable kit
- Patient saline option administers saline to keep access lines open
- Real-time fluid balance tracking
The Amicus ECP system, including the Phelix Photoactivation Device, is not cleared and not available in the United States.
Certain devices, software versions, and protocols may not be available depending on approval or clearance by the appropriate regulatory agencies in each country. Contact a Fresenius Kabi representative for questions on the regulatory status in your country.
